PimedBio

  • ABOUT US
    About Us

    We create new treatments
    based on cutting-edge approaches.

    • STARTUP STORY
    • HISTORY
    • LEADERSHIP
    • PARTNERSHIP & COLLABORATION
    • LOCATION
  • PLATFORM
    Platform

    We create new treatments
    based on cutting-edge approaches.

    • Platform Technology
  • PIPELINE
    Pipeline

    We create new treatments
    based on cutting-edge approaches.

    • OVERVIEW
    • Oncology
    • IMMUNOLOGY
  • PR
    PR

    We create new treatments
    based on cutting-edge approaches.

    • News
    • Notice
    • IR
  • CAREER
    CAREER

    We create new treatments
    based on cutting-edge approaches.

    • Recruitment notice
    • Join us
EN
  • KR
  • About Us
    • Startup story
    • History
    • Leadership
    • Partnership & Collaboration
    • Location
  • Platform
    • Platform technology
  • Pipeline
    • Overview
    • Oncology
      • Inhibitor-drug conjugates: IDC
      • The 3rd-Generation Immuno-oncology therapeutics
    • Immunology
      • PMB702(Novel IBD therapeutics)
  • PR
    • News
    • Notice
    • IR
  • Creer
    • Recruitment notice
    • Join Us

PR

Based on innovative scientific achievements,
Pimedbio's first-in-class drugs
  • News
  • Notice
  • IR
  • home
  • PR
  • News

  • News
    2019.08.26
    KDDF, 내달 5~6일 '약물타깃·개발 가능성' 주제 R&D워크숍
  • News
    2019.04.15
    이영호 대구첨복재단 이사장 "합성의약품에 기회있다"
  • News
    2019.03.11
    한국 바이오벤처의 시작…'럭키' 인맥
  • News
    2018.06.05
    '타이틀' 내던진 제약 고수들, 바이오벤처에 둥지
  • News
    2018.02.21
    바이오 1세대 재창업…성공신화 다시 쓴다
  • News
    2018.02.10
    한국파스퇴르연구소 스타트업 기업 입주식 개최
  • News
    2017.12.05
    벤처캐피탈협회, ‘2017 이머징 기술포럼’ 개최
  • News
    2017.11.14
    "제약기업 지금이 기회다"…동아쏘시오홀딩스 2017 하반기 리더십 특강
  • News
    2017.10.10
    크리스탈지노믹스 핵심 연구원들, 바이오벤처 설립
1 2

2nd floor, H2233, Healthcare Innovation Park, Bundang Seoul National University Hospital, 172 Dolmaro, Bundang-gu, Seongnam-si, Gyeonggi-do
Tel. 031-8039-7240 Fax. 050-4001-4874
  • 개인정보처리방침
  • 이메일무단수집거부
Copyright(C) Pimedbio. All Rights Reseved.